Ainos AIMD Peer Comparison

NASDAQ AIMD
$1.47 -0.01 (-0.67%)
As of: Sep 9, 2026 · 3:59 PM EDT
Peer Comparison

300 Comparable Companies

Industry Test and Measurement

Ainos, Inc. (AIMD) is the 300th largest of 300 Test and Measurement companies by market capitalisation, at 11.81 Mn, behind Data I/O Corp at 29.52 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 TER Teradyne, Inc primary T-15 Computer Hardware TG-02 55.83 Bn 50.44 12.51 55.51 Bn
2 KEYS Keysight Technologies, Inc. primary T-15 Computer Hardware TG-02 55.70 Bn 43.74 8.46 53.10 Bn
3 VIAV Viavi Solutions Inc. primary T-15 Computer Hardware TG-02 8.61 Bn -256.42 5.67 7.96 Bn
4 FORM Formfactor Inc primary T-15 Computer Hardware TG-02 8.12 Bn 73.54 9.00 7.77 Bn
5 RAL Ralliant Corp primary T-15 Computer Hardware TG-02 7.02 Bn -5.74 3.21 6.75 Bn
6 INTT Intest Corp primary T-15 Computer Hardware TG-02 0.14 Bn 142.35 1.11 0.12 Bn
7 LGL Lgl Group Inc primary T-15 Computer Hardware TG-02 0.05 Bn -281.69 10.70 0.05 Bn
8 DAIO Data I/O Corp primary T-15 Computer Hardware TG-02 0.03 Bn -3.57 2.01 0.03 Bn
9 AIMD Ainos, Inc. primary T-15 Computer Hardware TG-02 0.01 Bn -0.81 868.71 0.01 Bn
10 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 663.08 Bn 31.49 6.77 642.33 Bn
11 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 453.04 Bn 71.80 7.04 446.51 Bn
12 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 370.87 Bn 117.16 5.57 363.78 Bn
13 KLAC Kla Corp secondary T-03 Semiconductors TG-01 242.58 Bn 50.39 17.86 240.93 Bn
14 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 236.37 Bn 27.00 6.20 222.38 Bn
15 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn -64.83 6.15 184.12 Bn
16 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 31.45 10.99 130.51 Bn
17 EMR Emerson Electric Co secondary I-10 Machinery IG-02 85.23 Bn 33.11 4.57 83.07 Bn
18 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 85.09 Bn 19.66 5.48 77.10 Bn
19 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 63.93 Bn 36.92 12.23 58.75 Bn
20 COR Cencora, Inc. secondary H-19 Healthcare Payers and Distributors HG-05 63.13 Bn 24.21 0.19 60.51 Bn
21 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 58.07 Bn -18.38 26.07 52.94 Bn
22 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 53.95 Bn 11.58 1.01 46.98 Bn
23 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.34 Bn 60.81 2.45 38.68 Bn
24 IDXX Idexx Laboratories Inc /De secondary H-05 Pharmaceuticals and Biotechnology HG-01 42.23 Bn 37.09 9.27 42.03 Bn
25 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 35.59 Bn 45.89 7.41 32.28 Bn
26 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 39.08 3.25 31.34 Bn
27 ZTS Zoetis Inc. secondary H-05 Pharmaceuticals and Biotechnology HG-01 31.39 Bn 9.67 3.30 29.72 Bn
28 TDY Teledyne Technologies Inc secondary I-02 Aerospace and Defense IG-01 28.32 Bn 29.01 4.44 27.98 Bn
29 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn -31.36 24.23 26.41 Bn
30 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 26.24 Bn -14.72 8.48 12.58 Bn
31 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.47 Bn 15.75 4.38 20.94 Bn
32 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn -16.96 2,310.98 25.93 Bn
33 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.70 Bn 22.24 2.20 18.30 Bn
34 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 16.77 Bn 18.91 11.83 15.82 Bn
35 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 16.02 Bn 16.58 3.48 14.40 Bn
36 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 22.28 4.69 15.42 Bn
37 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn -49.43 12.28 14.93 Bn
38 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.69 Bn 17.20 6.03 13.85 Bn
39 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.62 Bn -21.18 20.50 13.91 Bn
40 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.96 Bn — — 13.27 Bn
41 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 176.35 3.78 12.00 Bn
42 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 31.25 7.55 12.34 Bn
43 ELAN Elanco Animal Health Inc secondary H-05 Pharmaceuticals and Biotechnology HG-01 12.21 Bn -61.37 2.43 11.68 Bn
44 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn -45.49 18.20 10.58 Bn
45 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 74.93 14.45 11.63 Bn
46 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
47 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.81 Bn -69.64 13.92 10.49 Bn
48 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.51 Bn 19.74 3.34 9.91 Bn
49 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
50 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn -54.84 — 10.11 Bn
51 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.99 Bn 789.75 2.73 9.85 Bn
52 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn -26.87 — 9.06 Bn
53 CHWY Chewy, Inc. secondary S-04 Branded Foods SG-02 9.70 Bn 38.38 0.76 9.18 Bn
54 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn -45.28 11.01 7.57 Bn
55 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.42 Bn 87.02 33.42 9.42 Bn
56 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn -8.36 — 8.86 Bn
57 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.57 Bn 17.97 10.72 7.89 Bn
58 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn -8.55 51.33 8.15 Bn
59 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -14.99 — 8.10 Bn
60 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn -42.14 — 7.84 Bn
61 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
62 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.07 Bn -33.52 29.47 6.74 Bn
63 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -734.96 5,007.81 6.97 Bn
64 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.73 Bn -17.90 — 6.73 Bn
65 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.59 Bn -29.38 1,058.74 6.59 Bn
66 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn -7.43 10.57 6.10 Bn
67 NPO Enpro Inc. secondary I-10 Machinery IG-02 6.28 Bn 141.89 5.13 6.20 Bn
68 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -16.08 — 5.96 Bn
69 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -33.18 1,163.52 5.66 Bn
70 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
71 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn -16.41 — 5.78 Bn
72 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn 15.04 5.72 3.55 Bn
73 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn 29.05 19.58 4.33 Bn
74 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn -17.55 — 5.06 Bn
75 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn -23.96 — 4.68 Bn
76 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.63 Bn — — 4.23 Bn
77 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn -13.51 402.01 4.16 Bn
78 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn -7.58 — 4.07 Bn
79 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.78 — 4.02 Bn
80 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.98 Bn -18.93 12.25 3.68 Bn
81 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn -16.67 16.41 3.01 Bn
82 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -31.20 — 3.80 Bn
83 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -32.98 70.47 2.78 Bn
84 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -8.13 32.18 3.06 Bn
85 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.72 Bn -521.64 4.64 3.43 Bn
86 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn -8.16 987.61 3.56 Bn
87 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn -21.21 52.94 3.50 Bn
88 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn -10.05 19,714.47 3.11 Bn
89 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn -15.22 — 3.04 Bn
90 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -11.21 593.06 2.51 Bn
91 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn 109.49 6.47 2.76 Bn
92 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.23 — 2.96 Bn
93 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.57 6.55 2.24 Bn
94 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -80.78 — 2.80 Bn
95 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.73 Bn -22.89 553.22 2.73 Bn
96 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -8.51 73.73 2.27 Bn
97 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.67 Bn 4.61 0.06 -3.12 Bn
98 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.60 Bn -6.02 36.49 2.60 Bn
99 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.59 Bn -174.08 10.31 2.48 Bn
100 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -6.44 — 2.59 Bn
101 NEOG Neogen Corp secondary H-08 Medical Devices and Diagnostics HG-02 2.58 Bn -363.11 2.96 2.39 Bn
102 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.59 4.75 2.19 Bn
103 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.53 Bn -29.70 3.21 2.16 Bn
104 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
105 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 13.72 2.56 1.65 Bn
106 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -20.64 44.92 1.77 Bn
107 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
108 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -17.30 1.20 1.58 Bn
109 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.03 — 2.10 Bn
110 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -21.96 13.89 2.36 Bn
111 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -7.91 44.88 2.34 Bn
112 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.30 Bn -10.51 — 1.93 Bn
113 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn -9.16 — 2.22 Bn
114 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -15.84 109.75 2.19 Bn
115 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 13.20 4.23 2.03 Bn
116 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.17 0.34 0.66 Bn
117 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -35.67 11.42 2.05 Bn
118 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 6.66 6.86 1.69 Bn
119 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -14.21 56.15 1.81 Bn
120 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,082.32 2.08 Bn
121 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -12.36 18.84 1.60 Bn
122 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.78 20.06 1.97 Bn
123 ZD Ziff Davis, Inc. secondary C-07 Advertising and Media CG-02 1.95 Bn 3.08 1.47 0.34 Bn
124 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -3.72 35.35 1.39 Bn
125 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -7.59 6.35 1.93 Bn
126 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -9.47 67.43 1.57 Bn
127 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -101.76 4.32 0.98 Bn
128 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -6.99 — 1.32 Bn
129 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -10.09 7.27 1.29 Bn
130 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn -4.55 — 1.80 Bn
131 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -14.23 1,370.98 1.78 Bn
132 BFLY Butterfly Network, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 1.75 Bn -25.77 15.62 1.62 Bn
133 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -27.67 — 1.39 Bn
134 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -207.39 1,008.79 1.73 Bn
135 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
136 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -12.73 — 1.71 Bn
137 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -6.79 4.07 0.97 Bn
138 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -118.55 16.97 1.68 Bn
139 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -9.11 20.12 1.38 Bn
140 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -68.24 8.28 1.36 Bn
141 VPG Vishay Precision Group, Inc. secondary I-04 Machinery IG-02 1.61 Bn 403.47 4.90 1.54 Bn
142 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
143 PAHC Phibro Animal Health Corp secondary H-05 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 15.55 1.02 1.47 Bn
144 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -8.49 — 1.53 Bn
145 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -11.47 969.66 1.31 Bn
146 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -3.37 2.10 1.22 Bn
147 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -9.00 — 1.50 Bn
148 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -14.58 72.74 1.45 Bn
149 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -6.70 — 1.42 Bn
150 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn -5.85 165.97 0.88 Bn
151 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 80.09 35.55 1.37 Bn
152 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -1.48 — 1.36 Bn
153 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -8.83 — 1.33 Bn
154 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.32 Bn -27.62 5.09 0.90 Bn
155 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.85 26.37 0.82 Bn
156 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.18 — 0.74 Bn
157 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -7.93 — 1.26 Bn
158 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -4.90 — 1.26 Bn
159 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -28.78 3.20 1.15 Bn
160 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -18.17 — 1.25 Bn
161 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -12.42 51.51 1.24 Bn
162 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -27.82 — 1.00 Bn
163 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -20.55 — 1.18 Bn
164 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -9.12 41.06 0.55 Bn
165 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -9.77 — 1.10 Bn
166 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn -118.02 — 1.06 Bn
167 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.93 Bn
168 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -15.63 4.14 0.71 Bn
169 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -72.45 — 0.95 Bn
170 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -16.83 2.09 0.66 Bn
171 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -4.90 14.37 0.57 Bn
172 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn 2.80 3.28 0.81 Bn
173 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 20.87 8.50 0.50 Bn
174 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -16.32 881.20 0.88 Bn
175 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.86 Bn -11.07 104.97 0.86 Bn
176 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn -4.78 — 0.85 Bn
177 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -8.36 — 0.84 Bn
178 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -10.71 44.17 0.48 Bn
179 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -6.79 — 0.79 Bn
180 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -124.74 2.37 0.63 Bn
181 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -6.55 — 0.71 Bn
182 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.12 8.48 0.61 Bn
183 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 12.59 5.40 0.51 Bn
184 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 554.70 9.71 0.41 Bn
185 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -3.61 — 0.49 Bn
186 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 3.17 1.81 0.62 Bn
187 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn -17.73 1,120.86 0.62 Bn
188 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -8.59 — 0.67 Bn
189 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 5.25 1.75 0.40 Bn
190 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -362,547.56 — 0.64 Bn
191 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -12.60 16.37 0.58 Bn
192 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -10.36 — 0.63 Bn
193 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 65.43 1.94 0.05 Bn
194 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -10.13 3.65 0.47 Bn
195 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -6.80 — 0.59 Bn
196 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -12.04 — 0.58 Bn
197 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -3.91 557.79 0.41 Bn
198 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -4.84 — 0.56 Bn
199 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.54 Bn -6.55 2.25 0.28 Bn
200 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -16.03 326.79 0.40 Bn
201 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -10.27 78.36 0.28 Bn
202 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.66 9.32 0.22 Bn
203 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -15.37 — 0.50 Bn
204 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.49 Bn -6.01 330.55 0.49 Bn
205 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 15.82 2.57 0.42 Bn
206 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 16.24 2.11 0.39 Bn
207 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -8.13 — 0.47 Bn
208 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.83 — 0.45 Bn
209 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -3.41 — 0.47 Bn
210 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -4.85 13.19 0.21 Bn
211 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -5.63 100.68 0.36 Bn
212 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.72 15.31 0.26 Bn
213 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.45 Bn 7.48 — 0.45 Bn
214 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.68 44.52 0.24 Bn
215 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -5.85 — 0.44 Bn
216 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.58 42.40 0.44 Bn
217 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -7.97 19.43 0.16 Bn
218 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.45 — 0.43 Bn
219 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -6.49 6.28 0.22 Bn
220 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.27 — 0.24 Bn
221 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -1.28 139.55 0.21 Bn
222 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.78 — 0.38 Bn
223 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.38 Bn -8.69 0.45 0.27 Bn
224 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
225 DMAC DiaMedica Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -11.03 — 0.36 Bn
226 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.16 — 0.36 Bn
227 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 3.71 2.65 0.34 Bn
228 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.13 — 0.34 Bn
229 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -6.68 — 0.33 Bn
230 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.93 3.70 0.17 Bn
231 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.05 104.23 0.33 Bn
232 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -7.83 5.52 0.16 Bn
233 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -4.33 — 0.31 Bn
234 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.31 Bn -4.97 6.82 0.26 Bn
235 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -10.84 — 0.31 Bn
236 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.58 4.90 0.30 Bn
237 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 64.31 — 0.19 Bn
238 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.32 13.14 0.29 Bn
239 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.29 7.86 0.22 Bn
240 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.03 0.01 -10.78 Bn
241 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -17.36 1.67 0.17 Bn
242 ANIK Anika Therapeutics, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -130.42 2.31 0.24 Bn
243 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -3.35 — 0.28 Bn
244 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.82 59.24 0.28 Bn
245 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -7.64 — 0.27 Bn
246 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -3.12 19.81 0.10 Bn
247 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -4.35 23.24 0.27 Bn
248 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -18.88 — 0.15 Bn
249 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.82 1.20 0.11 Bn
250 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -13.77 — 0.25 Bn
251 PYXS Pyxis Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.77 17.81 0.21 Bn
252 NMRA Neumora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -1.49 — 0.25 Bn
253 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 6.88 3.31 0.16 Bn
254 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -3.15 4.34 0.08 Bn
255 GLSI Greenwich LifeSciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -10.43 — 0.23 Bn
256 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.42 — 0.23 Bn
257 ABOS Acumen Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.20 — 0.23 Bn
258 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -5.11 54.32 0.23 Bn
259 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -1.16 — 0.23 Bn
260 ALOT AstroNova, Inc. secondary I-01 Aerospace and Defense IG-01 0.22 Bn -58.22 1.48 0.22 Bn
261 KROS Keros Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.49 6.84 -0.03 Bn
262 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.37 7.58 0.22 Bn
263 ORGO Organogenesis Holdings Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.22 Bn -2.20 0.48 0.17 Bn
264 CHRS Coherus Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.66 4.31 0.11 Bn
265 PRQR ProQR Therapeutics N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -4.44 10.20 0.08 Bn
266 ARMP Armata Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.46 — 0.19 Bn
267 PEPG PepGen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.99 — 0.22 Bn
268 VYGR Voyager Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.58 6.23 0.10 Bn
269 PLX Protalix BioTherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 10.05 2.66 0.17 Bn
270 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.27 — 0.21 Bn
271 ADAG Adagene Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -13.14 32.66 0.21 Bn
272 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.55 15.49 0.17 Bn
273 ORMP Oramed Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 1.21 — 0.21 Bn
274 NBP NovaBridge Biosciences secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -2.47 — 0.20 Bn
275 IPHA Innate Pharma SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.16 60.09 0.19 Bn
276 QNCX Quince Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.55 — 0.34 Bn
277 NGEN Nervgen Pharma Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -116.03 — 0.19 Bn
278 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.61 75.57 0.06 Bn
279 MOLN Molecular Partners Ag secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.51 214.11 0.18 Bn
280 XLO Xilio Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.57 2.72 0.04 Bn
281 ADCT ADC Therapeutics SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.42 2.28 -0.05 Bn
282 MDWD MediWound Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -4.87 14.38 0.14 Bn
283 RANI Rani Therapeutics Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.96 33.39 0.17 Bn
284 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 2,035.87 -0.02 Bn
285 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.91 — 0.16 Bn
286 NRXP NRX Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -6.25 43.96 0.12 Bn
287 MIST Milestone Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
288 ENTX Entera Bio Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -10.49 — 0.14 Bn
289 OKUR OnKure Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.87 — -0.03 Bn
290 UNCY Unicycive Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.06 — 0.14 Bn
291 CUE Cue Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -1.72 6.38 0.13 Bn
292 MSLE Satellos Bioscience Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.56 — 0.14 Bn
293 CRBP Corbus Pharmaceuticals Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.02 Bn
294 IBIO iBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.13 1,363.19 0.14 Bn
295 HURA TuHURA Biosciences, Inc./NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.47 — 0.14 Bn
296 RFL Rafael Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -5.01 136.38 0.14 Bn
297 VANI Vivani Medical, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.77 — 0.11 Bn
298 TLSA Tiziana Life Sciences Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -6.55 — 0.12 Bn
299 BDTX Black Diamond Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.55 — 0.01 Bn
300 INO Inovio Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.50 — 0.12 Bn